US Patent Issued to EXELIXIS on July 14 for "PD-L1 binding agents and uses thereof" (Wisconsin, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,893, issued on July 14, was assigned to EXELIXIS INC. (Alameda, Calif.).

"PD-L1 binding agents and uses thereof" was invented by Bryan Glaser (Madison, Wis.), Bonnie Hammer (Madison, Wis.) and Seema Kantak (Pacifica, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides PD-L1 binding agents (e.g., antibodies, including multispecific antibodies, such as bispecific antibodies) and uses thereof."

The patent was filed on Aug. 3, 2021, under Application No. 18/018,863.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fne...